U · A
Unknown Author
January 23, 2026
Kirkland Counsels Coalesce Capital on Examinetics Investment

1 min
AI-made summary
- Kirkland & Ellis advised private equity firm Coalesce Capital on its investment in Examinetics, a provider of occupational health compliance testing services
- Coalesce is partnering with existing shareholder Freedom 3 Capital for the recapitalization
- The investment aims to support Examinetics' expansion into new and existing markets and the introduction of new technologies and services
- The Kirkland legal team was led by partners Ted Frankel, Kevin Mausert, Ziyad Ziyadzade, and associates Joshua Bass and Mickal Haile.
Kirkland & Ellis provided legal advice to private equity firm Coalesce Capital on its investment in occupational health compliance testing services provider Examinetics. Coalesce is partnering with existing Examinetics shareholder Freedom 3 Capital on the recapitalization. Examinetics plans to accelerate its expansion in existing and new markets and introduce new technologies and services with the investment. Read the Coalesce Capital press release The Kirkland team was led by corporate partners Ted Frankel, Kevin Mausert and Ziyad Ziyadzade, as well as associates Joshua Bass and Mickal Haile.
U
Article Author
Unknown Author
The Sponsor
